Abarca, Janet .

HRN: 29-39-28  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/29/2026
08/04/2026
IV
4.5g
Q8h
Non Healing Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: